Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features - 19/08/20
Doi : 10.1016/j.jpeds.2020.06.057
Anne H. Rowley, MD ⁎ 
Department of Pediatrics and of Microbiology and Immunology, Northwestern University Feinberg School of Medicine, The Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
∗Reprint requests: Anne H. Rowley, MD, The Ann & Robert H. Lurie Children's Hospital of Chicago, 225 E Chicago Ave, Box #205, Chicago, IL 60611The Ann & Robert H. Lurie Children's Hospital of Chicago225 E Chicago AveBox #205ChicagoIL60611
Abbreviations : COVID-19, MIS-C, SARS-CoV-2
Le texte complet de cet article est disponible en PDF.
| Funded by the National Institutes of Health R21AI140029 (to A.R.), the Feitler Family, the Max Goldenberg Foundation, and the Center for Kawasaki Disease at the Ann & Robert H. Lurie Children's Hospital of Chicago. A.R. is the co-inventor on a provisional patent application related to antibodies and antigens of Kawasaki Disease, serial number 62/811,930. |
© 2020
Elsevier Inc. Tous droits réservés.
Vol 224
P. 129-132 - septembre 2020 Retour au numéro
Article précédent
- Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use
- Kathryn M. Edwards, Walter A. Orenstein
- Bridging Prenatal and Pediatric Care: A Proposed Simple Yet Novel Approach to Preventing Family Violence
- Melissa A. Bright, Lindsay A. Thompson, Dikea Roussos-Ross, Diana Montoya-Williams, Nancy Hardt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?